バイオサージェリーの世界市場分析・予測

◆英語タイトル:MediPoint: Biosurgery - Global Analysis and Market Forecast
◆商品コード:GDME0229MAR
◆発行会社(調査会社):GlobalData
◆発行日:2016年6月14日
◆ページ数:175
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,995 ⇒換算¥683,430見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD11,990 ⇒換算¥1,366,860見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD17,985 ⇒換算¥2,050,290見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、バイオサージェリーの世界市場について調査・分析し、以下の構成でお届けいたします。
・イントロダクション
・バイオサージェリー産業概観
・アンメットニーズ分析
・バイオサージェリーの市場機会分析
・市場の成長要因および阻害要因
・競争分析
・バイオサージェリーの製品パイプライン分析
・バイオサージェリーの治験動向
・主要企業分析
・バイオサージェリーの世界市場規模予測
・バイオサージェリーの地域別市場規模予測
【レポートの概要】

MediPoint: Biosurgery – Global Analysis and Market Forecast

Summary

Prompt hemostasis, effective incision closure, tissue and vessel sealing, and post-operative adhesion prevention have been paramount concerns for surgeons for decades. As medical technology advances, the surgeon’s toolbox expands to include more effective products that actively cease bleeding, close external and internal ruptures in tissue, and provide physical barriers between tissues to prevent dangerous adhesions. These biosurgery products have become indispensable keystones in any operating room environment.

Biosurgery products are experiencing steady growth across many countries. Emerging markets are expected to demonstrate the highest growth among the 15 market covered in the report, which are the US, Canada, Mexico, France, Germany, Italy, Spain, Russia, UK, Japan, China, India, South Korea, Australia, and Brazil.

The taxonomy of biosurgery included in this report covers hemostats, tissue sealants, tissue adhesives, and surgical adhesion barriers.

The global biosurgery market features two main players: J&J and Baxter. Other prominent players include CryoLife, Sanofi, Pfizer, Integra LifeSciences, C.R. Bard, and B. Braun.

The entire market will be driven by aging populations, higher volumes of surgical procedures, and an increasing number of technological innovations.

Key Opinion Leaders emphasize the need for better mechanical properties, optimal biocompatibility, and need for less expensive products.

Highlights

Key Questions Answered

- What is the current and future biosurgery market outlook in the developed and emerging markets? What trends are affecting the global market?
- Which are the key, high growth sectors of interest? Which markets segments are growing the fastest?
- What are the unmet needs with biosurgery products currently on the market? How will future developments fulfill these unmet needs?
- What are the physician perception s of biosurgery products?
- What are the challenges that have hindered widespread adoption?
- How will emerging trends and changing market landscapes affect the future of this space?

Key Findings

- Emerging economies are seeing the highest growth in the global biosurgery market.
- Hemostats and tissue sealants make up the largest portions of the market in many countries because they are widely used in a variety of different surgical specialties.
- The most successful firms involved in biosurgery are providing comprehensive portfolios, undertaking key M&A’s, fostering innovation, and focusing wisely on emerging markets to stay competitive.
- Rising numbers of different surgical procedures are the primary drivers of the biosurgery market. Despite respectable adoption, unmet needs and non-clinical barriers remain a challenge.

Scope

- Overview of different hemostats, sealants, adhesives, and adhesion prevention products available to surgeons.
- Annualized total biosurgery market revenue by segment and market outlooks by country through 2022.
- Key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access, and implications of the emerging technologies on the market.
- Analysis of the current and future market competition in the biosurgery market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to –
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global biosurgery market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific markets from 2013-2022.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

【レポートの目次】

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 8
1.2 List of Figures 12
2 Introduction 15
2.1 Catalyst 15
2.2 Related Reports 16
3 Market Access 17
3.1 Reimbursement 17
3.2 Regulation 18
3.2.1 North America 18
3.2.2 Europe 20
3.2.3 Asia-Pacific 20
3.3 Key Mergers, Acquisitions, Deals, and Partnerships 21
4 Unmet Needs 23
4.1 Overview 23
4.2 Optimal Mechanical Properties 23
4.3 Preparation and Storage 24
4.4 Safety Concerns 24
4.5 Better Biocompatibility 25
4.6 Emergency and Military Use of Hemostats 26
5 Competitive Assessment 28
5.1 Company Share Analysis 28
5.1.1 Global Overview 28
5.1.2 North America 29
5.1.3 Europe 30
5.1.4 Asia-Pacific 30
5.2 Major Players 31
5.2.1 Advanced Medical Solutions 31
5.2.2 B. Braun 33
5.2.3 Atrium Medical 36
5.2.4 Baxter 37
5.2.5 C.R. Bard 40
5.2.6 CryoLife 43
5.2.7 Gelita 45
5.2.8 Sanofi 47
5.2.9 Integra LifeSciences 48
5.2.10 Ethicon Endo-Surgery (Johnson & Johnson) 51
5.2.11 Medtronic 56
5.2.12 Pfizer 58
5.2.13 Stryker 60
5.2.14 Takeda 62
5.3 Emerging Players 64
5.3.1 3-D Matrix Medical Technology 64
5.3.2 Adhezion Biomedical 66
5.3.3 Anika Therapeutics 67
5.3.4 BioActive Polymers 68
5.3.5 Chemence Medical 69
5.3.6 Cohera Medical 71
5.3.7 Gecko Biomedical 72
5.3.8 Hemostasis, LLC 73
5.3.9 HyperBranch Medical Technology 74
5.3.10 Mallinckrodt 75
5.3.11 Mast Biosurgery 77
5.3.12 OptMed 78
5.3.13 Sealantis 79
5.3.14 Vivostat 80
5.4 Distributors 81
6 Market Outlooks 82
6.1 Market Drivers and Barriers 82
6.1.1 Driver: Growing Surgery Markets 82
6.1.2 Driver: Curtailing the Impact of Excessive Blood Loss 83
6.1.3 Driver: The Multi-functionality of Fibrin 83
6.1.4 Driver: Novel Materials and Advanced Features 84
6.1.5 Barrier: Growth of Laparoscopic Procedures 85
6.1.6 Barrier: Mechanical Wound Closure Devices 86
6.1.7 Barrier: Coagulation and Tissue Sealing Using Surgical Energy 86
6.1.8 Barrier: Steep Costs 87
6.1.9 Barrier: Regulatory Problems 88
6.2 Market Outlooks by Segment 88
6.2.1 Global Overview 88
6.2.2 Hemostats 91
6.2.3 Tissue Sealants 97
6.2.4 Tissue Adhesives 104
6.2.5 Surgical Adhesion Barriers 110
6.3 Market Outlooks by Geography 117
6.3.1 Global Overview 117
6.3.2 North America 122
6.3.3 Europe 126
6.3.4 Asia-Pacific 130
6.3.5 South America (Brazil) 134
6.4 Segment Share by Country 138
6.4.1 US 138
6.4.2 Canada 139
6.4.3 Mexico 140
6.4.4 France 140
6.4.5 Germany 141
6.4.6 Italy 142
6.4.7 Russia 142
6.4.8 Spain 143
6.4.9 UK 143
6.4.10 Australia 144
6.4.11 China 144
6.4.12 India 145
6.4.13 Japan 145
6.4.14 South Korea 146
6.4.15 Brazil 147
7 Appendix 148
7.1 Bibliography 148
7.2 Abbreviations 168
7.3 Methodology 169
7.3.1 Overview 169
7.3.2 Coverage 169
7.3.3 Secondary Research 169
7.4 Forecasting Methodology 171
7.5 Primary Research Efforts 171
7.6 About the Authors 172
7.6.1 Shashank Settipalli, Analyst, Medical Devices 172
7.6.2 Linda Tian, Msc, Managing Analyst, Medical Devices 172
7.6.3 David Brady, Director of Operations – Market Research 172
7.6.4 Tyler Fletcher, Global Head of Medical Devices 173
7.7 About GlobalData 174
7.8 Disclaimer 174

1.1 List of Tables
Table 1: Sample HCPCS Codes for Biosurgery Products 17
Table 2: Recent FDA Approvals and Clearances of Biosurgery Products 19
Table 3: Key Deals in the Biosurgery Space (2013-2016) 22
Table 4: Advanced Medical Solutions Company Profile 31
Table 5: Advanced Medical Solutions SWOT Analysis, 2016 32
Table 6: Key Marketed Products from Advanced Medical Solutions 33
Table 7: B. Braun Company Profile 34
Table 8: B. Braun SWOT Analysis, 2016 34
Table 9: Key Marketed Products from B. Braun 35
Table 10: Atrium Medical Company Profile 36
Table 11: Getinge SWOT Analysis, 2016 36
Table 12: Key Marketed Products from Atrium Medical 37
Table 13: Baxter Company Profile 38
Table 14: Baxter SWOT Analysis, 2016 38
Table 15: Key Marketed Products from Baxter 39
Table 16: C.R. Bard Company Profile 41
Table 17: C.R. Bard SWOT Analysis, 2016 41
Table 18: Key Marketed Products from C.R. Bard 42
Table 19: CryoLife Company Profile 43
Table 20: CryoLife SWOT Analysis, 2016 44
Table 21: Key Marketed Products from CryoLife 44
Table 22: Gelita Company Profile 45
Table 23: Gelita SWOT Analysis, 2016 46
Table 24: Key Marketed Products from Gelita 46
Table 25: Sanofi Company Profile 47
Table 26: Sanofi SWOT Analysis, 2016 47
Table 27: Key Marketed Products from Sanofi 48
Table 28: Integra LifeSciences Company Profile 49
Table 29: Integra LifeSciences SWOT Analysis, 2016 49
Table 30: Key Marketed Products from Integra Lifesciences 50
Table 31: Ethicon Company Profile 51
Table 32: Ethicon SWOT Analysis, 2016 52
Table 33: Key Marketed Products from Ethicon 53
Table 34: Medtronic Company Profile 56
Table 35: Medtronic SWOT Analysis, 2016 57
Table 36: Key Marketed Products from Medtronic 58
Table 37: Pfizer Company Profile 58
Table 38: Pfizer SWOT Analysis, 2016 59
Table 39: Key Marketed Products from Pfizer 59
Table 40: Stryker Company Profile 60
Table 41: Stryker SWOT Analysis, 2016 61
Table 42: Key Marketed Products from Stryker 62
Table 43: Takeda Company Profile 63
Table 44: Takeda SWOT Analysis, 2016 63
Table 45: Key Marketed Products from Takeda 64
Table 46: 3-D Matrix Medical Technology Company Profile 65
Table 47: 3-D Matrix Medical Technology SWOT Analysis, 2016 65
Table 48: Key Marketed Products from 3-D Matrix Medical Technology 66
Table 49: Adhezion Biomedical Company Profile 67
Table 50: Key Marketed Products from Adhezion Biomedical 67
Table 51: Anika Therapeutics Company Profile 68
Table 52: Key Marketed Products from Anika Therapeutics 68
Table 53: BioActive Polymers Company Profile 69
Table 54: Key Pipeline Products from BioActive Polymers 69
Table 55: Chemence Medical Company Profile 70
Table 56: Key Marketed Products from Chemence Medical 70
Table 57: Cohera Medical Company Profile 71
Table 58: Key Marketed Products from Advanced Medical Solutions 72
Table 59: Gecko Biomedical Company Profile 72
Table 60: Hemostasis Company Profile 73
Table 61: Key Marketed Products from Hemostasis 74
Table 62: HyperBranch Company Profile 74
Table 63: Key Marketed Products from Hemostasis 75
Table 64: Mallinckrodt Company Profile 76
Table 65: Key Marketed Products from Mallinckrodt 76
Table 66: Mast Biosurgery Company Profile 77
Table 67: Key Marketed Products from Mast Biosurgery 77
Table 68: OptMed Company Profile 78
Table 69: Key Marketed Products from OptMed 79
Table 70: Sealantis Company Profile 79
Table 71: Key Marketed Products from Sealantis 80
Table 72: Vivostat Company Profile 80
Table 73: Major Distributors of Biosurgery Products 81
Table 74: Global Market Value Forecast by Segment for Biosurgery, $m, 2013-2022 90
Table 75: North America Market Value Forecast by Segment for Hemostats, $m, 2013-2022 93
Table 76: Europe Market Value Forecast by Segment for Hemostats, $m, 2013-2022 94
Table 77: Asia-Pacific Market Value Forecast by Segment for Hemostats, $m, 2013-2022 95
Table 78: Brazil Market Value Forecast by Segment for Hemostats, $m, 2013-2022 96
Table 79: North America Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022 99
Table 80: Europe Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022 101
Table 81: Asia-Pacific Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022 102
Table 82: Brazil Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022 104
Table 83: North America Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022 106
Table 84: Europe Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022 107
Table 85: Asia-Pacific Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022 109
Table 86: Brazil Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022 110
Table 87: North America Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022 113
Table 88 : Europe Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022 114
Table 89 : Asia-Pacific Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022 115
Table 90 : Brazil Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022 116
Table 91 : Global Market Value Forecast by Country for Biosurgery, $m, 2013-2022 118

1.2 List of Figures
Figure 1: Global Company Market Share for Biosurgery, 2015 28
Figure 2: North America Company Market Share for Biosurgery, 2015 29
Figure 3: Europe Company Market Share for Biosurgery, 2015 30
Figure 4: Global Market Forecast for Biosurgery by Segment, 2013-2022 89
Figure 5: Global Market Forecast for Hemostats by Segment, 2013-2022 91
Figure 6: North America Market Forecast for Hemostats by Segment, 2013-2022 92
Figure 7: Europe Market Forecast for Hemostats by Segment, 2013-2022 94
Figure 8: Asia-Pacific Market Forecast for Hemostats by Segment, 2013-2022 95
Figure 9: Brazil Market Forecast for Hemostats by Segment, 2013-2022 96
Figure 10: Global Market Forecast for Tissue Sealants by Segment, 2013-2022 97
Figure 11: North America Market Forecast for Tissue Sealants by Segment, 2013-2022 98
Figure 12: Europe Market Forecast for Tissue Sealants by Segment, 2013-2022 100
Figure 13: Asia-Pacific Market Forecast for Tissue Sealants by Segment, 2013-2022 102
Figure 14: Brazil Market Forecast for Tissue Sealants by Segment, 2013-2022 103
Figure 15: Global Market Forecast for Tissue Adhesives by Segment, 2013-2022 105
Figure 16: North America Market Forecast for Tissue Adhesives by Segment, 2013-2022 106
Figure 17: Europe Market Forecast for Tissue Adhesives by Segment, 2013-2022 107
Figure 18: Asia-Pacific Market Forecast for Tissue Adhesives by Segment, 2013-2022 108
Figure 19: Brazil Market Forecast for Tissue Adhesives by Segment, 2013-2022 109
Figure 20: Global Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022 111
Figure 21: North America Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022 112
Figure 22: Europe Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022 113
Figure 23: Asia-Pacific Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022 115
Figure 24: Brazil Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022 116
Figure 25: Global Market Forecast for Biosurgery by Country, 2013-2022 117
Figure 26: Global Biosurgery Market Comparison by Country, 2015 and 2022 119
Figure 27: Global Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022 120
Figure 28: Global Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022 121
Figure 29: Global Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022 122
Figure 30: North America Market Forecast for Biosurgery by Country, 2013-2022 123
Figure 31: North America Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022 124
Figure 32: North America Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022 125
Figure 33: North America Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022 126
Figure 34: Europe Market Forecast for Biosurgery by Country, 2013-2022 127
Figure 35: Europe Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022 128
Figure 36: Europe Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022 129
Figure 37: Europe Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022 130
Figure 38: Asia-Pacific Market Forecast for Biosurgery by Country, 2013-2022 131
Figure 39: Asia-Pacific Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022 132
Figure 40: Asia-Pacific Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022 133
Figure 41: Asia-Pacific Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022 134
Figure 42: Brazil Market Forecast for Biosurgery by Country, 2013-2022 135
Figure 43: Brazil Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022 136
Figure 44: Brazil Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022 137
Figure 45: Brazil Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022 138
Figure 46: US Biosurgery Market Share by Segment, 2015 139
Figure 47: Canada Biosurgery Market Share by Segment, 2015 139
Figure 48: Mexico Biosurgery Market Share by Segment, 2015 140
Figure 49: France Biosurgery Market Share by Segment, 2015 141
Figure 50: Germany Biosurgery Market Share by Segment, 2015 141
Figure 51: Italy Biosurgery Market Share by Segment, 2015 142
Figure 52: Russia Biosurgery Market Share by Segment, 2015 142
Figure 53: Spain Biosurgery Market Share by Segment, 2015 143
Figure 54: UK Biosurgery Market Share by Segment, 2015 143
Figure 55: Australia Biosurgery Market Share by Segment, 2015 144
Figure 56: China Biosurgery Market Share by Segment, 2015 144
Figure 57: India Biosurgery Market Share by Segment, 2015 145
Figure 58: Japan Biosurgery Market Share by Segment, 2015 146
Figure 59: South Korea Biosurgery Market Share by Segment, 2015 146
Figure 60: Brazil Biosurgery Market Share by Segment, 2015 147

【掲載企業】

Advanced Medical Solutions
B. Braun
Atrium Medical
Baxter
C.R. Bard
CryoLife
Gelita
Sanofi
Integra LifeSciences
Ethicon Endo-Surgery (Johnson & Johnson)
Medtronic
Pfizer
Stryker
Takeda
3-D Matrix Medical Technology
Adhezion Biomedical
Anika Therapeutics
BioActive Polymers
Chemence Medical
Cohera Medical
Gecko Biomedical
Hemostasis, LLC
HyperBranch Medical Technology
Mallinckrodt
Mast Biosurgery
OptMed
Sealantis
Vivostat

【レポートのキーワード】

バイオサージェリー

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[バイオサージェリーの世界市場分析・予測]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月08日現在 219,203 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆